Bank Of New York Mellon Corp Agenus Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$0.53 - $0.93 $49,937 - $87,625	-94,221 Reduced 6.36%	1,386,408 $804 Million
Q4 2023 Jan 29, 2024	BUY	$0.63 - $1.14 $141,082 - $255,291	223,940 Added 17.82%	1,480,629 $1.23 Billion
Q3 2023 Oct 24, 2023	BUY	$1.12 - $1.88 $10,811 - $18,147	9,653 Added 0.77%	1,256,689 $1.42 Billion
Q2 2023 Aug 03, 2023	BUY	$1.31 - $2.04 $350,552 - $545,897	267,597 Added 27.32%	1,247,036 $2 Billion
Q1 2023 May 09, 2023	BUY	$1.45 - $2.95 $1.42 Million - $2.89 Million	979,439 New	979,439 $1.49 Billion
Q4 2022 Feb 14, 2023	BUY	$2.02 - $3.25 $2.03 Million - $3.27 Million	1,004,907 New	1,004,907 $2.41 Million
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.14 $294,531 - $471,850	150,271 Added 17.24%	1,021,846 $2.1 Million
Q2 2022 Aug 15, 2022	BUY	$1.3 - $2.64 $135,047 - $274,251	103,883 Added 13.53%	871,575 $1.69 Million
Q1 2022 May 11, 2022	BUY	$2.35 - $3.47 $67,210 - $99,242	28,600 Added 3.87%	767,692 $1.89 Million
Q4 2021 Feb 11, 2022	BUY	$2.92 - $5.74 $258,037 - $507,238	88,369 Added 13.58%	739,092 $2.38 Million
Q3 2021 Nov 12, 2021	BUY	$4.98 - $6.63 $152,895 - $203,554	30,702 Added 4.95%	650,723 $3.42 Million
Q2 2021 Aug 11, 2021	BUY	$2.56 - $5.49 $122,073 - $261,790	47,685 Added 8.33%	620,021 $3.4 Million
Q1 2021 May 13, 2021	SELL	$2.69 - $5.25 $31,774 - $62,013	-11,812 Reduced 2.02%	572,336 $1.56 Million
Q4 2020 Feb 09, 2021	BUY	$3.17 - $4.49 $3,661 - $5,185	1,155 Added 0.2%	584,148 $1.86 Million
Q3 2020 Nov 12, 2020	BUY	$2.98 - $5.2 $111,201 - $194,043	37,316 Added 6.84%	582,993 $2.33 Million
Q2 2020 Aug 12, 2020	BUY	$2.29 - $4.24 $170,737 - $316,125	74,558 Added 15.83%	545,677 $2.14 Million
Q1 2020 May 06, 2020	SELL	$1.92 - $4.39 $1,560 - $3,569	-813 Reduced 0.17%	471,119 $1.15 Million
Q4 2019 Feb 14, 2020	SELL	$2.41 - $4.4 $14,676 - $26,796	-6,090 Reduced 1.27%	471,932 $1.92 Million
Q3 2019 Nov 07, 2019	BUY	$2.17 - $3.14 $37,846 - $54,764	17,441 Added 3.79%	478,022 $1.23 Million
Q2 2019 Aug 12, 2019	SELL	$2.53 - $3.04 $19,655 - $23,617	-7,769 Reduced 1.66%	460,581 $1.38 Million
Q1 2019 May 14, 2019	BUY	$2.51 - $3.73 $63,914 - $94,980	25,464 Added 5.75%	468,350 $1.39 Million
Q4 2018 Feb 11, 2019	BUY	$1.59 - $2.66 $147,801 - $247,265	92,957 Added 26.56%	442,886 $1.06 Million
Q3 2018 Nov 09, 2018	SELL	$1.59 - $2.42 $105,620 - $160,755	-66,428 Reduced 15.95%	349,929 $0
Q2 2018 Aug 06, 2018	SELL	$2.26 - $4.65 $37,640 - $77,445	-16,655 Reduced 3.85%	416,357 $945,000
Q1 2018 May 15, 2018	BUY	$3.51 - $6.04 $73,067 - $125,734	20,817 Added 5.05%	433,012 $2.04 Million
Q4 2017 Feb 09, 2018	BUY	$3.26 - $4.78 $1.34 Million - $1.97 Million	412,195	412,195 $1.34 Million

Others Institutions Holding AGEN

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account